MTOR and neoplasm: Ectopic expression of miR-218 revealed that miR-218 exerted its tumor suppressive effects in OSCC cells by targeting the rapamycin-insensitive component of mTOR or Rictor with consequent inhibition of AKT S473 phosphorylation and inactivation of PI3K/AKT signaling [101].